Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma.
Karam JA, Msaouel P, Haymaker CL, Matin SF, Campbell MT, Zurita AJ, Shah AY, Wistuba II, Marmonti E, Duose DY, Parra ER, Soto LMS, Laberiano-Fernandez C, Lozano M, Abraham A, Hallin M, Chin CD, Olson P, Der-Torossian H, Yan X, Tannir NM, Wood CG.
Karam JA, et al. Among authors: tannir nm.
Nat Commun. 2023 May 10;14(1):2684. doi: 10.1038/s41467-023-38342-7.
Nat Commun. 2023.
PMID: 37164948
Free PMC article.
Clinical Trial.